- call +1-201-465-4211
- email sales@mrinsights.biz
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
Scope of the Report:
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.
The worldwide market for Short Bowel Syndrome is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Short Bowel Syndrome in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Shire
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
GLP-2
Growth Hormone
Glutamine
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
There are 15 Chapters to deeply display the global Short Bowel Syndrome market.
Chapter 1, to describe Short Bowel Syndrome Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Short Bowel Syndrome, with sales, revenue, and price of Short Bowel Syndrome, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Short Bowel Syndrome, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Short Bowel Syndrome market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Short Bowel Syndrome sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Short Bowel Syndrome Introduction
1.2 Market Analysis by Type
1.2.1 GLP-2
1.2.2 Growth Hormone
1.2.3 Glutamine
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shire
2.1.1 Business Overview
2.1.2 Short Bowel Syndrome Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Shire Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Short Bowel Syndrome Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Emmaus Life Sciences
2.3.1 Business Overview
2.3.2 Short Bowel Syndrome Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Emmaus Life Sciences Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Nutrinia
2.4.1 Business Overview
2.4.2 Short Bowel Syndrome Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Nutrinia Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlyPharma Therapeutics
2.5.1 Business Overview
2.5.2 Short Bowel Syndrome Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlyPharma Therapeutics Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 OxThera
2.6.1 Business Overview
2.6.2 Short Bowel Syndrome Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 OxThera Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ardelyx
2.7.1 Business Overview
2.7.2 Short Bowel Syndrome Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ardelyx Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sancilio & Company
2.8.1 Business Overview
2.8.2 Short Bowel Syndrome Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sancilio & Company Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Naia Pharmaceuticals
2.9.1 Business Overview
2.9.2 Short Bowel Syndrome Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Naia Pharmaceuticals Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Zealand Pharma
2.10.1 Business Overview
2.10.2 Short Bowel Syndrome Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Zealand Pharma Short Bowel Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Short Bowel Syndrome Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Short Bowel Syndrome Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Short Bowel Syndrome Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Short Bowel Syndrome Manufacturer Market Share in 2017
3.3.2 Top 6 Short Bowel Syndrome Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Short Bowel Syndrome Market Analysis by Regions
4.1 Global Short Bowel Syndrome Sales, Revenue and Market Share by Regions
4.1.1 Global Short Bowel Syndrome Sales and Market Share by Regions (2013-2018)
4.1.2 Global Short Bowel Syndrome Revenue and Market Share by Regions (2013-2018)
4.2 North America Short Bowel Syndrome Sales and Growth Rate (2013-2018)
4.3 Europe Short Bowel Syndrome Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Short Bowel Syndrome Sales and Growth Rate (2013-2018)
4.5 South America Short Bowel Syndrome Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Short Bowel Syndrome Sales and Growth Rate (2013-2018)
5 North America Short Bowel Syndrome by Countries
5.1 North America Short Bowel Syndrome Sales, Revenue and Market Share by Countries
5.1.1 North America Short Bowel Syndrome Sales and Market Share by Countries (2013-2018)
5.1.2 North America Short Bowel Syndrome Revenue and Market Share by Countries (2013-2018)
5.2 United States Short Bowel Syndrome Sales and Growth Rate (2013-2018)
5.3 Canada Short Bowel Syndrome Sales and Growth Rate (2013-2018)
5.4 Mexico Short Bowel Syndrome Sales and Growth Rate (2013-2018)
6 Europe Short Bowel Syndrome by Countries
6.1 Europe Short Bowel Syndrome Sales, Revenue and Market Share by Countries
6.1.1 Europe Short Bowel Syndrome Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Short Bowel Syndrome Revenue and Market Share by Countries (2013-2018)
6.2 Germany Short Bowel Syndrome Sales and Growth Rate (2013-2018)
6.3 UK Short Bowel Syndrome Sales and Growth Rate (2013-2018)
6.4 France Short Bowel Syndrome Sales and Growth Rate (2013-2018)
6.5 Russia Short Bowel Syndrome Sales and Growth Rate (2013-2018)
6.6 Italy Short Bowel Syndrome Sales and Growth Rate (2013-2018)
7 Asia-Pacific Short Bowel Syndrome by Countries
7.1 Asia-Pacific Short Bowel Syndrome Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Short Bowel Syndrome Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Short Bowel Syndrome Revenue and Market Share by Countries (2013-2018)
7.2 China Short Bowel Syndrome Sales and Growth Rate (2013-2018)
7.3 Japan Short Bowel Syndrome Sales and Growth Rate (2013-2018)
7.4 Korea Short Bowel Syndrome Sales and Growth Rate (2013-2018)
7.5 India Short Bowel Syndrome Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Short Bowel Syndrome Sales and Growth Rate (2013-2018)
8 South America Short Bowel Syndrome by Countries
8.1 South America Short Bowel Syndrome Sales, Revenue and Market Share by Countries
8.1.1 South America Short Bowel Syndrome Sales and Market Share by Countries (2013-2018)
8.1.2 South America Short Bowel Syndrome Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Short Bowel Syndrome Sales and Growth Rate (2013-2018)
8.3 Argentina Short Bowel Syndrome Sales and Growth Rate (2013-2018)
8.4 Colombia Short Bowel Syndrome Sales and Growth Rate (2013-2018)
9 Middle East and Africa Short Bowel Syndrome by Countries
9.1 Middle East and Africa Short Bowel Syndrome Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Short Bowel Syndrome Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Short Bowel Syndrome Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Short Bowel Syndrome Sales and Growth Rate (2013-2018)
9.3 UAE Short Bowel Syndrome Sales and Growth Rate (2013-2018)
9.4 Egypt Short Bowel Syndrome Sales and Growth Rate (2013-2018)
9.5 Nigeria Short Bowel Syndrome Sales and Growth Rate (2013-2018)
9.6 South Africa Short Bowel Syndrome Sales and Growth Rate (2013-2018)
10 Global Short Bowel Syndrome Market Segment by Type
10.1 Global Short Bowel Syndrome Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Short Bowel Syndrome Sales and Market Share by Type (2013-2018)
10.1.2 Global Short Bowel Syndrome Revenue and Market Share by Type (2013-2018)
10.2 GLP-2 Sales Growth and Price
10.2.1 Global GLP-2 Sales Growth (2013-2018)
10.2.2 Global GLP-2 Price (2013-2018)
10.3 Growth Hormone Sales Growth and Price
10.3.1 Global Growth Hormone Sales Growth (2013-2018)
10.3.2 Global Growth Hormone Price (2013-2018)
10.4 Glutamine Sales Growth and Price
10.4.1 Global Glutamine Sales Growth (2013-2018)
10.4.2 Global Glutamine Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Short Bowel Syndrome Market Segment by Application
11.1 Global Short Bowel Syndrome Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
12 Short Bowel Syndrome Market Forecast (2018-2023)
12.1 Global Short Bowel Syndrome Sales, Revenue and Growth Rate (2018-2023)
12.2 Short Bowel Syndrome Market Forecast by Regions (2018-2023)
12.2.1 North America Short Bowel Syndrome Market Forecast (2018-2023)
12.2.2 Europe Short Bowel Syndrome Market Forecast (2018-2023)
12.2.3 Asia-Pacific Short Bowel Syndrome Market Forecast (2018-2023)
12.2.4 South America Short Bowel Syndrome Market Forecast (2018-2023)
12.2.5 Middle East and Africa Short Bowel Syndrome Market Forecast (2018-2023)
12.3 Short Bowel Syndrome Market Forecast by Type (2018-2023)
12.3.1 Global Short Bowel Syndrome Sales Forecast by Type (2018-2023)
12.3.2 Global Short Bowel Syndrome Market Share Forecast by Type (2018-2023)
12.4 Short Bowel Syndrome Market Forecast by Application (2018-2023)
12.4.1 Global Short Bowel Syndrome Sales Forecast by Application (2018-2023)
12.4.2 Global Short Bowel Syndrome Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Short Bowel Syndrome Picture
Table Product Specifications of Short Bowel Syndrome
Figure Global Sales Market Share of Short Bowel Syndrome by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
